B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.

MLA

Collins, Christopher E., et al. “B Lymphocyte Stimulator (BLyS) Isoforms in Systemic Lupus Erythematosus: Disease Activity Correlates Better with Blood Leukocyte BLyS MRNA Levels than with Plasma BLyS Protein Levels.” Arthritis Research & Therapy, vol. 8, no. 1, 2006, p. R6. EBSCOhost, https://doi.org/10.1186/ar1855.

APA

Collins, C. E., Gavin, A. L., Migone, T.-S., Hilbert, D. M., Nemazee, D., & Stohl, W. (2006). B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Research & Therapy, 8(1), R6. https://doi.org/10.1186/ar1855

Chicago

Collins, Christopher E, Amanda L Gavin, Thi-Sau Migone, David M Hilbert, David Nemazee, and William Stohl. 2006. “B Lymphocyte Stimulator (BLyS) Isoforms in Systemic Lupus Erythematosus: Disease Activity Correlates Better with Blood Leukocyte BLyS MRNA Levels than with Plasma BLyS Protein Levels.” Arthritis Research & Therapy 8 (1): R6. doi:10.1186/ar1855.